company with the primary mission to bring promising biopharmaceutical
products to market, was given the People’s Choice Award.
Red Path Integrated Pathology Inc., an early stage diagnostic services
company, was selected as the Company Most
Likely to Receive Funding.
In addition to the 19 presenting companies, Bio Life Tech
welcomed four dynamic featured speakers. Mr. Jeff Singer, Vice
President, the NASDAQ Stock Market, offered an inside look at
the NASDAQ stock market. Mr. Osagie Imasogie, Co-Founder and
Managing Partner, Phoenix IP Ventures, discussed trends in the
Steve Hurly, Janney Montgomery Scott, discussed the state
of the bio industry. Dr. Wise Young, one of the world’s
leading neuroscientists, highlighted the developments in stem
The Bio Life Tech 2005 Venture Conference was successful in
matching entrepreneurs with investors, creating new business
opportunities in the bio life science industry on the East Coast.
Bio Life Tech 2005: Accelerating the Pace of Opportunity.